<DOC>
	<DOCNO>NCT00063596</DOCNO>
	<brief_summary>Extremely low birth weight infant decrease blood level Vitamin A . This Vitamin A deficiency may increase risk infection chronic lung disease infant . This study examine effect Vitamin A supplementation premature baby bear weigh less 1500 gram ( 3.3 lb ) .</brief_summary>
	<brief_title>Vitamin A Supplementation Preterm Infants</brief_title>
	<detailed_description>Vitamin A derivative retinoic acid ( RA ) recognize important factor potentiate immune response protect infection . In develop nation , Vitamin A deficiency associate infectious gastroenteritis increase susceptibility number infection , measles . RA important regulator cell growth differentiation augment IgM production core blood mononuclear cell response polyclonal B-cell activator . This augmentation immunoglobulin secretion mediate effect RA T B cell , part production certain cytokine ( e.g. , IL-6 IL-10 ) important terminal differentiation B-cells plasma cell . In animal model , correction Vitamin A deficiency improve immune response vaccination . Infants extremely low birth weight low plasma tissue concentration Vitamin A. Vitamin A supplementation pre-term infant reduce chronic lung disease risk sepsis . Because immune system pre-term infant immature , response pre-term infant Hepatitis B vaccine diminish compare full-term baby . This study determine whether Vitamin A supplementation pre-term infant enhance response infant immunization Hepatitis B vaccine . The study also evaluate effect Vitamin A supplementation survival , chronic lung disease , infection rate . Low birth weight pre-term infant randomize receive either Vitamin A supplementation placebo . The Vitamin A treatment group receive 5,000 IU Vitamin A ( retinyl palmitate ) intramuscular injection 3 time weekly 28 day start postnatal day 2 . To avoid pain discomfort , placebo group receive sham procedure rather placebo saline injection . The staff neonatal intensive care unit retain responsibility decision regard use therapy , parental fluid , mechanical ventilation , glucocorticoid , hyperalimentation , blood replacement . All infant assess potential Vitamin A toxicity . While neonatal intensive care unit , infant blood test Days 0 , 14 , 30 , 60 . After discharge neonatal intensive care unit , patient return clinic assessment blood sample Months 4 , 6 , 9 . Infants give Hepatitis B vaccine 2 , 4 , 6 month chronological age . Primary outcome measure include Hepatitis B antibody level , chronic lung disease , rate infection neonatal intensive care unit , incidence severity infection first 9 month life .</detailed_description>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin A</mesh_term>
	<mesh_term>Retinol palmitate</mesh_term>
	<criteria>Inclusion Criteria Born le 32 week gestation Weigh le 1500 g ( 3.3 lb ) 500 g ( 1.1 lb )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>3 Days</maximum_age>
	<verification_date>November 2004</verification_date>
	<keyword>Vitamin A</keyword>
	<keyword>Hepatitis B vaccine</keyword>
	<keyword>Immune response</keyword>
	<keyword>T-cell subset</keyword>
	<keyword>Chronic lung disease</keyword>
	<keyword>Cytokines , intracytoplasmic</keyword>
	<keyword>Antibodies , hepatitis B tetanus toxoid</keyword>
</DOC>